Press Releases

Company press releases and official corporate announcements.

A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.

Articles

24,446 total articles

Orange County Bancorp, Inc. Declares Cash Dividend

Orange County Bancorp, Inc. Declares Cash Dividend

Orange County Bancorp, Inc., the parent company of Orange Bank & Trust Company and Orange Investment Advisors, announced a cash dividend of $0.18 per share, payable on June 15, 2026 to shareholders of record as of June 4, 2026. This reflects the company's commitment to returning value to its shareholders amid its growth to $2.6 billion in assets.

XTL Announces Receipt of Staff Delist Determination from Nasdaq

XTL Announces Receipt of Staff Delist Determination from Nasdaq

XTL Biopharmaceuticals Ltd. has received a formal notice from Nasdaq's Listing Qualifications Department indicating potential delisting from the Nasdaq Capital Market due to failure to timely file its Annual Report on Form 20-F for 2025, along with previously disclosed deficiencies involving minimum stockholders’ equity and bid price requirements. …

Maris-Tech Announces Receipt of Nasdaq Notification of Minimum Stockholders’ Equity Non-Compliance

Maris-Tech Announces Receipt of Nasdaq Notification of Minimum Stockholders’ Equity Non-Compliance

Maris-Tech Ltd. announced it received a notification from Nasdaq indicating non-compliance with the minimum stockholders' equity requirement of $2.5 million, reporting equity of approximately $601,583 as of December 31, 2025. The company has until July 6, 2026 to submit a plan to regain compliance and may receive an extension if the plan is accepte…

Abivax Presents First Quarter 2026 Financial Results and Reports Three-Year Interim Data from Study 108, a Phase 2a/2b Open-Label Extension Trial of Obefazimod Following Dose De-Escalation in Patients with Ulcerative Colitis

Abivax Presents First Quarter 2026 Financial Results and Reports Three-Year Interim Data from Study 108, a Phase 2a/2b Open-Label Extension Trial of Obefazimod Following Dose De-Escalation in Patients with Ulcerative Colitis

Abivax SA disclosed its Q1 2026 financial results alongside promising three-year interim data from Study 108, a Phase 2a/2b open-label extension trial of obefazimod in moderately to severely active ulcerative colitis (UC) patients. The study shows durable clinical remission rates of 68% after dose de-escalation to 25 mg over 144 weeks, with no new …

All In FutureTech Alliance Long-Term Strategic Direction Following the HyalRoute Acquisition: Building a Future Technology Platform Driven by AI Infrastructure and AI Applications, with Optical Technologies at Its Core

All In FutureTech Alliance Long-Term Strategic Direction Following the HyalRoute Acquisition: Building a Future Technology Platform Driven by AI Infrastructure and AI Applications, with Optical Technologies at Its Core

All In FutureTech Alliance Inc. (Nasdaq: AGAE) announced its strategic direction following the acquisition of a controlling interest in HyalRoute Fiber-Optic Communication Group, a company owning extensive fiber-optic networks in Southeast Asia and submarine cable assets. The acquisition marks a key milestone in AIFA's transformation from an experi…

European Commission grants marketing authorization to Pharming’s Joenja® (leniolisib) – the first approved treatment for APDS in the European Union

European Commission grants marketing authorization to Pharming’s Joenja® (leniolisib) – the first approved treatment for APDS in the European Union

Pharming Group has secured European Commission marketing authorization for Joenja® (leniolisib), the first approved treatment for activated phosphoinositide 3-kinase delta (PI3Kδ) syndrome (APDS) in the EU. This approval expands the drug's global reach, already approved in the US, UK, Japan, Australia, and Israel, with planned European launch start…

Scilex Holding Company (“Scilex”) Announces Its Board of Directors Approved a Dividend of Semnur Pharmaceuticals, Inc. Common Stock to Holders of Scilex Common Stock and other Eligible Equity Securities with a Record Date of June 1, 2026

Scilex Holding Company (“Scilex”) Announces Its Board of Directors Approved a Dividend of Semnur Pharmaceuticals, Inc. Common Stock to Holders of Scilex Common Stock and other Eligible Equity Securities with a Record Date of June 1, 2026

Scilex Holding Company, a Nasdaq-listed biopharmaceutical firm specializing in non-opioid pain management products, declared a dividend distribution of Semnur Pharmaceuticals, Inc. common stock to its eligible shareholders as of June 1, 2026. This dividend correlates to one share of Semnur for each Scilex common share held. The move reflects Scilex…

Cuprina Holdings announces 1-for-8 Share Consolidation

Cuprina Holdings announces 1-for-8 Share Consolidation

Cuprina Holdings plans a 1-for-8 share consolidation effective around May 27, 2026, to comply with Nasdaq listing rules and maintain its listing on the Nasdaq Capital Market. The consolidation will convert every eight existing shares into one new share, adjusting the par value accordingly. This move aims to strengthen the company's capital markets …

SemiLux International Ltd. Announces Receipt of Nasdaq Staff Determination Letter and Intention to Request Hearing

SemiLux International Ltd. Announces Receipt of Nasdaq Staff Determination Letter and Intention to Request Hearing

SemiLux International Ltd. received a Nasdaq Staff Determination Letter notifying the company of its pending delisting from The Nasdaq Capital Market due to failure to meet minimum bid price and stockholders' equity requirements and outstanding Form 20-F filings. The company plans to request a hearing and submit a compliance plan to regain listing …

Allsteel Introduces Flourish, A Design-Forward Collaborative Chair

Allsteel Introduces Flourish, A Design-Forward Collaborative Chair

Allsteel, a brand under HNI Corporation, has introduced Flourish, a new collaborative chair designed for evolving work environments emphasizing flexibility and individuality. Featuring a distinctive petaled back and customizable base options, Flourish aims to enhance comfort and design expression in various office spaces. The chair meets rigorous e…

XMax Announces Additional AI Services Agreement Expected to Generate Up to Approximately $3.6 Million in Annual Revenue

XMax Announces Additional AI Services Agreement Expected to Generate Up to Approximately $3.6 Million in Annual Revenue

XMax Inc., through its subsidiary XMax AI Inc., has entered a new AI Model API Services Agreement with a new customer. The contract, estimated to generate up to $3.6 million annually, involves providing cloud-based AI model API services and infrastructure. This agreement highlights growing enterprise demand for scalable AI deployment solutions and …

South Jersey Industries, Inc. Announces Amendment and Extension of Cash Tender Offer for Any and All of the Outstanding 2018 Series A 3.70% Remarketable Junior Subordinated Notes due 2031

South Jersey Industries, Inc. Announces Amendment and Extension of Cash Tender Offer for Any and All of the Outstanding 2018 Series A 3.70% Remarketable Junior Subordinated Notes due 2031

South Jersey Industries, Inc. announced an amendment and extension to its cash tender offer for all outstanding 2018 Series A 3.70% Remarketable Junior Subordinated Notes due 2031, increasing the total consideration from $920 to $955 per $1,000 principal amount and extending the expiration time to May 29, 2026. The offer remains subject to customar…

Futu Receives Investigation Notice and Administrative Penalty Pre-Notification Letter from the China Securities Regulatory Commission

Futu Receives Investigation Notice and Administrative Penalty Pre-Notification Letter from the China Securities Regulatory Commission

Futu Holdings Limited disclosed that it has received a Notice of Investigation and an Administrative Penalty Pre-Notification Letter from the China Securities Regulatory Commission related to unlicensed securities, fund sales, and futures business activities by its mainland China and Hong Kong entities. The CSRC proposes penalties amounting to appr…

BioAge Labs to Present at Upcoming Investor Conferences

BioAge Labs to Present at Upcoming Investor Conferences

BioAge Labs, a clinical-stage biotechnology company focusing on therapies for metabolic diseases through targeting human aging biology, announced participation in upcoming healthcare investor conferences hosted by Jefferies and Goldman Sachs. The company will present updates on its lead candidate BGE-102, a brain-penetrant NLRP3 inhibitor with prom…